Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $29 | $31 | $32 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $13 | $11 | $12 | $15 |
| Inventory | $9 | $8 | $8 | $8 |
| Other Curr. Assets | $2 | $1 | $2 | $2 |
| Total Curr. Assets | $49 | $50 | $52 | $56 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $9 | $8 | $8 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $58 | $60 | $65 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $0 | $1 |
| Other Curr. Liab. | $6 | $6 | $6 | $7 |
| Total Curr. Liab. | $11 | $11 | $10 | $11 |
| LT Debt | $39 | $39 | $39 | $38 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $40 | $40 | $40 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $5 | $5 |
| Total Liabilities | $51 | $51 | $50 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$88 | -$86 | -$82 | -$78 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $94 | $93 | $93 | $92 |
| Total Equity | $6 | $7 | $11 | $14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $57 | $58 | $60 | $65 |
| Net Debt | $14 | $10 | $8 | $7 |